Concepedia

Rebecca G. Anderson

RG

Statistics

Publications

6

Citations

351

H-Index

6

Active since

1998

Affiliations

Atrium Health Wake Forest Baptist(Current)

Rebecca G. Anderson is an author at Atrium Health Wake Forest Baptist specializing in life sciences, oncology, and pharmacology.

Publications per year

1998–2023

6

Publications

6

Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development

Gabriela Rennebeck, Elena Kleymenova, Rebecca G. Anderson et al. · Proceedings of the National Academy of Sciences · 1998 · 107 citations

Life Sciences, Developmental Biology, Genetics +17

A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna et al. · Clinical Cancer Research · 2018 · 107 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Tight junction protein ZO-2 expression and relative function of ZO-1 and ZO-2 during mouse blastocyst formation

Bhavwanti Sheth, Rachael L. Nowak, Rebecca G. Anderson et al. · Experimental Cell Research · 2008 · 49 citations

Life Sciences, Cell Biology, Developmental Biology +17

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia

Rebecca G. Anderson, Lance D. Miller, Scott Isom et al. · Nature Communications · 2022 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia

Rebecca G. Anderson, Kristin M. Pladna, Nathaniel J. Schramm et al. · Cancers · 2023 · 30 citations · Full text

Life Sciences, Oncology, Pharmacology +14

1–5 of 6